A new study shows daily supplementation with 300 mg of CoQ10 significantly increases antioxidant capacity and reduces inflammation levels and oxidative stress levels after surgery for patients with hepatocellular carcinoma (HCC), the most common type of liver cancer.
41 patients with hepatocellular carcinoma (HCC) participated in this single-blinded, randomized, parallel, placebo-controlled study. A random numbers table was used to randomly assign the participants to receive either the CoQ10 (300 mg) or a placebo. The study lasted 12 weeks. The levels of antioxidant enzymes activity was significantly increased in the CoQ10 supplement group. Additionally the CoQ10 group had significantly decreased oxidative stress and inflammatory markers levels when compared to the placebo group.
Larger and longer studies are needed to confirm the benefits seen with CoQ10 supplementation in patients with HCC taken after surgery.
CoQ 10 is a cell oxygenator and supports the transfer of oxygen between the cells. It is an antioxidant and supports cardiovascular health by promoting energy on a cellular level. Scientific studies show Co Q 10 is three times more bioavailable when delivered in an oil based softgel capsule.
ASK US. WE KNOW. NOBODY KNOWS NUTRITION LIKE WE DO. NOBODY !